For example, MALAT1 leads to the epithelial-to-mesenchymal transition program through a phosphatidylinositide-3 kinase-AKT pathway in breast cancer, and thus MALAT1 is significantly downregulated in breast cancer tissues and cell lines (Zhao et al., 2014). Here, MALAT1 is linked to breast cancer.